Geoffrey S. Gottlieb

ORCID: 0000-0002-5749-481X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV, Drug Use, Sexual Risk
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • HIV-related health complications and treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Antimicrobial Resistance in Staphylococcus
  • Sex work and related issues
  • Viral-associated cancers and disorders
  • Cervical Cancer and HPV Research
  • Adolescent Sexual and Reproductive Health
  • Infective Endocarditis Diagnosis and Management
  • Immune Cell Function and Interaction
  • Genital Health and Disease
  • Herpesvirus Infections and Treatments
  • Cytomegalovirus and herpesvirus research
  • Hepatitis C virus research
  • Mycobacterium research and diagnosis
  • Food Security and Health in Diverse Populations
  • Bacterial Identification and Susceptibility Testing
  • Streptococcal Infections and Treatments
  • Poverty, Education, and Child Welfare
  • HIV/AIDS oral health manifestations

University of Washington
2016-2025

Massachusetts General Hospital
2020

Seattle University
2009-2019

National Institute of Allergy and Infectious Diseases
2018

National Clinical Research
2016

Imperial College London
2016

Office of Infectious Diseases
2010

University of Washington Medical Center
2000-2001

Duke University
1997-2000

Duke Medical Center
1999-2000

To determine whether recommendations of infectious diseases specialists affect outcome for patients, we evaluated 244 hospitalized patients with Staphylococcus aureus bacteremia. We offered our management to each patient's physicians and then assessed the clinical both whom consultative advice was followed those not heeded. All were up 12 weeks after their first positive blood culture. Our 112 (45.9%) partially or completely ignored 132 (54.1%). Patients more likely be cured S. infection...

10.1086/514686 article EN Clinical Infectious Diseases 1998-09-01

Fifty-nine consecutive patients with definite Staphylococcus aureus infective endocarditis (IE) by the Duke criteria were prospectively identified at our hospital over a 3-year period. Twenty-seven (45.8%) of 59 had hospital-acquired S. bacteremia. The presumed source infection was an intravascular device in 50.8% patients. Transthoracic echocardiography (TTE) revealed evidence IE 20 (33.9%), whereas transesophageal (TEE) 48 (81.4%). outcome for strongly associated echocardiographic...

10.1086/515076 article EN Clinical Infectious Diseases 1999-01-01

Human immunodeficiency virus (HIV) type 2 infection is characterized by slower disease progression to acquired syndrome than results from HIV-1 infection. To better understand the biological factors underlying different natural histories of with these retroviruses, we examined relationship between HIV RNA and DNA levels rate CD4+ T cell decline among 472 HIV-1- 114 HIV-2-infected individuals Senegal. The annual in HIV-2 cohort was approximately one-fourth that seen cohort. However, when...

10.1086/339295 article EN The Journal of Infectious Diseases 2002-04-01

To identify risk factors for relapse among 309 prospectively identified cases of Staphylococcus aureus bacteremia, patients with recurrent S. bacteremia were identified, and pulsed-field gel electrophoresis (PFGE) was performed on isolates from both episodes. PFGE banding patterns identical in 23 patients, consistent relapsed infection. Patients PFGE-confirmed more likely by univariate multivariate analyses to have an indwelling foreign body (odds ratio [OR] = 18.2, 95% confidence interval...

10.1086/314712 article EN The Journal of Infectious Diseases 1999-05-01

Background: Previous studies give conflicting results regarding the effect of age on outcomes in Staphylococcus aureus bacteremia (SAB).These have been limited by retrospective design or small sample size. Methods:We conducted a prospective cohort study 385 patients with SAB aged 18 to 90 years.The setting was large academic medical center.We observed from diagnosis discharge death.Discharged were contacted 12 weeks after their first positive culture findings.Data collected demographics,...

10.1001/archinte.159.11.1244 article EN Archives of Internal Medicine 1999-06-14

Selecting human immunodeficiency virus (HIV) sequences for inclusion within vaccines has been a difficult problem, as circulating HIV strains evolve relentlessly and become increasingly divergent over time. We report an assessment of this divergence from three perspectives: (i) across different hosts function time infection, (ii) between donors recipients in known transmission pairs, (iii) individual relation to the initially replicating deduced ancestral sequence intrahost viral population....

10.1128/jvi.80.4.1637-1644.2006 article EN Journal of Virology 2006-01-26

The V3 loop of the HIV-1 Env protein is primary determinant viral coreceptor usage, whereas V1V2 region thought to influence binding and participate in shielding neutralization-sensitive regions glycoprotein gp120 from antibody responses. functional properties antigenicity are influenced by changes amino acid sequence, sequence length patterns N-linked glycosylation. However, how these polymorphisms relate HIV pathogenesis not fully understood. We examined 5185 nucleotide fragments clinical...

10.1371/journal.ppat.1001228 article EN cc-by PLoS Pathogens 2010-12-16

Background. The compilation of previous genomewide association studies AIDS shows a major polymorphism in the HCP5 gene associated with both control viral load and long-term nonprogression (LTNP) to AIDS. Methods. To look for genetic variants that affect LTNP without necessary load, we reanalyzed data unique Genomics Resistance Immunodeficiency Virus (GRIV) cohort by excluding "elite controller" patients, who were controlling at very low levels (<100 copies/mL). Results. rs2234358 CXCR6 was...

10.1086/655782 article EN The Journal of Infectious Diseases 2010-08-12

Malnutrition and food insecurity are associated with increased mortality poor clinical outcomes among people living HIV/AIDS; however, the prevalence of malnutrition HIV/AIDS in Senegal, West Africa is unknown. The objective this study was to determine severity HIV-infected adults identify associations between insecurity, malnutrition, HIV outcomes.We conducted a cross-sectional at outpatient clinics Dakar Ziguinchor, Senegal. Data were collected using participant interviews, anthropometry,...

10.1371/journal.pone.0141819 article EN cc-by PLoS ONE 2015-11-03

Oral pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (F/TDF) has high efficacy against HIV-1 acquisition. Seventy-two prospective studies of daily oral F/TDF PrEP were conducted to evaluate incidence, drug resistance, adherence, and bone renal safety in diverse settings. incidence was calculated from incident diagnoses after initiation within 60 days discontinuation. Tenofovir concentrations dried blood spots (DBS), bone/renal indicators evaluated a subset...

10.1093/cid/ciae143 article EN cc-by Clinical Infectious Diseases 2024-03-14

HIV-2 is endemic in West Africa, but, unlike HIV-1, has had limited spread to other locales [1]. HIV-1 emerged Africa more recently and because cocirculate this region, some individuals become dually infected with both viruses [2,3]. Compared infection, infection characterized by a much longer asymptomatic stage, lower plasma viral loads, slower decline CD4 cell count, decreased mortality rate due AIDS, rates of mother-to-child transmission, genital tract shedding, sexual transmission...

10.1097/qad.0b013e32830edd44 article EN AIDS 2008-10-02

Background. The efficacy of various antiretroviral (ARV) therapy regimens for human immunodeficiency virus type 2 (HIV-2) infection remains unclear. HIV-2 is intrinsically resistant to the nonnucleoside reverse-transcriptase inhibitors and enfuvirtide may also be less susceptible than HIV-1 some protease (PIs). However, mutations in that confer ARV resistance are not well characterized. Methods. Twenty-three patients were studied as part an ongoing prospective longitudinal cohort study...

10.1086/596504 article EN Clinical Infectious Diseases 2009-01-14

A mean of 9-10 years human immunodeficiency virus type 1 (HIV-1) infection elapse before clinical AIDS develops in untreated persons, but this rate disease progression varies substantially among individuals. To investigate host genetic determinants the to AIDS, we performed a multistage genomewide association study.

10.1086/649842 article EN The Journal of Infectious Diseases 2010-01-11

Abstract Background: There is evidence of an interaction between HIV and human papillomavirus (HPV) resulting in increased HPV-associated morbidity cancer mortality among HIV-positive women. This study aims to determine how the natural history cervical HPV infection differs by status. Methods: A total 1,320 women (47% were positive for HIV-1 and/or HIV-2) followed average two years Senegal, West Africa 1994 2010. Cytology (with a sub-sample histology) DNA testing performed at approximately...

10.1158/1055-9965.epi-16-0700 article EN Cancer Epidemiology Biomarkers & Prevention 2017-05-18

The WHO guidelines for the management of advanced HIV disease recommend a package care consisting rapid initiation antiretroviral therapy (ART), enhanced screening and diagnosis tuberculosis (TB) cryptococcal meningitis, co-trimoxazole prophylaxis, isoniazid preventive (IPT), fluconazole pre-emptive therapy, adherence support. goals this study were to determine prevalence among individuals initiating ART in Senegal, identify predictors disease, evaluate guidelines.This was conducted...

10.1186/s12879-019-3826-5 article EN cc-by BMC Infectious Diseases 2019-03-15

Novel variants continue to emerge in the SARS-CoV-2 pandemic. University testing programs may provide timely epidemiologic and genomic surveillance data inform public health responses. We conducted from September 2021 February 2022 a university population under vaccination indoor mask mandates. A total of 3,048 24,393 individuals tested positive for by RT-PCR; whole genome sequencing identified 209 Delta 1,730 Omicron genomes 1,939 sequenced. Compared Delta, had shorter median serial...

10.1038/s41467-022-32786-z article EN cc-by Nature Communications 2022-09-06
Serge Eholié Didier K. Ekouévi Corine Chazallon Charlotte Charpentier Eugène Messou and 95 more Zélica Diallo Jacques Zoungrana Albert Minga Ndèye Fatou Ngom Gueye Denise Hawerlander Fassery Dembele Géraldine Colin Boris Tchounga Sophie Karcher Jérôme Le Carrou Annick Tchabert-Guié Thomas-d’Aquin Toni Abdoul–Salam Ouédraogo Guillaume Bado Coumba Touré Kane Moussa Seydi Armel Poda Ephrem Mensah I. Diallo Youssouf Joseph Drabo Xavier Anglaret Françoise Brun‐Vézinet Xavier Anglaret Lambert Assoumou Guillaume Bado E. Bissagnéné Fabrice Bonnet C.A.T. De Britto F. B. Vezinet Charlotte Charpentier Corine Chazallon Henri Chenal Geneviève Chêne Remy Chenier Gwenaëlle Clouet Géraldine Colin Gilles Collin Valérie Conte Christine Danel Laure‐Amélie de Monteynard Fassery Dembele Zélica Diallo I. Diallo Lambert Dohoun Youssouf Joseph Drabo Serge Eholié Didier K. Ekouévi Fatoumata Fadiga Delphine Gabillard Pierre Marie Girard Geoffrey S. Gottlieb Denise Hawerlander Sophie Karcher Benjamin Kariyiare Mame Basty Koita Fall Romuald Konan Antoine Kouamé Serge-Olivier Kouley Gabriele Laborde Bolen Roland Landman Jérôme Le Carrou Anne Geneviève Marcelain Sophie Matheron Ephrem Mensah Noémie Mercier Assoua Messou Eugène Messou Albert Minga Cheick Tidiane N'dour Célestin N’Chot Bara Ndiaye Ndèye Fatou Ngom Gueye Larissa N'guessan-Koffi Éric Ouattara Abdoul–Salam Ouédraogo Vincent Palokinam Pitché Gilles Peytavin Jean‐Christophe Plantier Armel Poda Mireille Prince-David Yasmine Raffali Claire Rekacewicz Christine Rouzioux Mounerou Salou Lassana Sangaré Adrien Sawadogo Moussa Seydi Désiré Somé Séphora Tamegnon Annick Tchabert-Guié Boris Tchounga Thomas d’Aquin Toni Coumba Touré Kane Pierre Touret J. Traoré

10.1016/s2352-3018(24)00085-7 article FR cc-by-nc-nd The Lancet HIV 2024-05-11
Coming Soon ...